- Issuer ticker
-
RGEN
- Reported as of
-
05 Oct 2026
- Net transaction value
-
-$1,036,654
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
06 Oct 2026, 16:18:26 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Jennifer Carmichael (Attorney in Fact)
Filing notes and source
Key filing fact
Olivier Loeillot filed Form 4 for REPLIGEN CORP (RGEN) on 06 Oct 2026.
Key facts
- This page summarizes Olivier Loeillot's Form 4 filing for REPLIGEN CORP (RGEN).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Oct 2026, 16:18.
Change
- Previous filing in this sequence was filed on 05 Oct 2026.
- Current net transaction value: -$1,036,654.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001995525
Primary reporting owner
Loeillot Olivier
- Relationship
-
Chief Executive Officer, Director
- Address
- C/O REPLIGEN CORPORATION, 41 SEYON ST., BLDG 1, STE 100, WALTHAM
- Signature
- /s/ Jennifer Carmichael (Attorney in Fact)
- Signature date
- 06 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RGEN
transaction
Common Stock
Sale
- Transaction value
- -$238,274
- Shares
- -1,333
- Change %
- -2.8%
- Price
-
$178.75
- Shares after
- 45,788
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
RGEN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,202
- Change %
- +9.2%
- Price
-
$154.96*
- Shares after
- 49,990
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
RGEN
transaction
Common Stock
Sale
- Transaction value
- -$798,380
- Shares
- -4,202
- Change %
- -8.4%
- Price
-
$190.00
- Shares after
- 45,788
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RGEN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -4,202
- Change %
- -33%
- Price
-
$0.000000*
- Shares after
- 8,405
- Date
- 05 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,202
- Exercise price
- $154.96
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses
2 footnotes